p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-alpha and melphalan.

Muret, J; Yacoub, M; Terrier, P; Drusch, F; Laplanche, A; Gaudin, C; Richon, C; Le Péchoux, C; Le Cesne, A; Lejeune, F J; Tursz, T; Fouret, P; Bonvalot, S; Chouaib, S

Muret, J; Yacoub, M; Terrier, P; Drusch, F; Laplanche, A; Gaudin, C; Richon, C; Le Péchoux, C; Le Cesne, A; Lejeune, F J; Tursz, T; Fouret, P; Bonvalot, S; Chouaib, S.

Affiliation

Muret J; Department of AnesthesiaInstitut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France. muret@igr.fr

Ann Oncol ; 19(4): 793-800, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18065405

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Chemotherapy, Cancer, Regional Perfusion / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Tumor Suppressor Protein p53 Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Francia

Search on Google

Add to My VHL

XML

PubMed Links